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A B S T R A C T   
The T-cell receptor (TCR) is a highly polymorphic surface receptor that allows T-cells to recognize antigenic 
peptides presented on the major histocompatibility complex (MHC). Changes in the TCR repertoire have been 
observed in several autoimmune conditions, and these changes are suggested to predispose autoimmunity. 
Multiple lines of evidence have implied an important role for T-cells in the pathogenesis of Systemic Sclerosis 
(SSc), a complex autoimmune disease. One of the major questions regarding the roles of T-cells is whether 
expansion and activation of T-cells observed in the diseases pathogenesis is antigen driven. 
To investigate the temporal TCR repertoire dynamics in SSc, we performed high-throughput sequencing of 
CD4+ and CD8+ TCRβ chains on longitudinal samples obtained from four SSc patients collected over a minimum 
of two years. Repertoire overlap analysis revealed that samples taken from the same individual over time shared 
a high number of TCRβ sequences, indicating a clear temporal persistence of the TCRβ repertoire in CD4+ as well 
as CD8+ T-cells. Moreover, the TCRβs that were found with a high frequency at one time point were also found 
with a high frequency at the other time points (even after almost four years), showing that frequencies of 
dominant TCRβs are largely consistent over time. We also show that TCRβ generation probability and observed 
TCR frequency are not related in SSc samples, showing that clonal expansion and persistence of TCRβs is caused 
by antigenic selection rather than convergent recombination. Moreover, we demonstrate that TCRβ diversity is 
lower in CD4+ and CD8+ T-cells from SSc patients compared with memory T-cells from healthy individuals, as 
SSc TCRβ repertoires are largely dominated by clonally expanded persistent TCRβ sequences. Lastly, using 
“Grouping of Lymphocyte Interactions by Paratope Hotspots” (GLIPH2), we identify clusters of TCRβ sequences 
with homologous sequences that potentially recognize the same antigens and contain TCRβs that are persist in 
SSc patients. 
In conclusion, our results show that CD4+ and CD8+ T-cells are highly persistent in SSc patients over time, and 
this persistence is likely a result from antigenic selection. Moreover, persistent TCRs form high similarity clusters 
with other (non-)persistent sequences that potentially recognize the same epitopes. These data provide evidence 
for an antigen driven expansion of CD4+/CD8+ T-cells in SSc.   
1. Introduction 
Systemic Sclerosis (SSc) is a complex chronic autoimmune disease, 
characterized by vascular abnormalities and widespread fibrosis 
affecting the skin and internal organs [1]. Although the pathogenic 
mechanisms underlying SSc remain largely unknown, multiple lines of 
evidence imply an important role for CD4+ and CD8+ T-cells in the 
progression of the disease. Activated T-cells infiltrate the skin of SSc 
patients already in the early phase of the disease [2,3]. These infiltrating 
T-cells can cross-talk with fibroblasts, inducing fibroblast activation and 
apoptosis through secretion of pro-inflammatory cytokines and fas/fas 
ligand engagement [4,5]. Moreover, T-cells isolated from SSc patients 
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undergo clonal expansion when cultured together with autologous fi-
broblasts, suggesting that auto-antigens presented by SSc fibroblasts can 
induce auto-reactive T-cell responses [6]. Apart from skin, peripheral 
blood T-cells from SSc patients also exhibit signs of activation and ex-
press activation markers, including IL-2R, HLA-DR, and CD29 [7–9], and 
secrete pro-inflammatory and pro-fibrotic factors [10–12]. 
The T-cell receptor (TCR) is a highly polymorphic surface receptor 
that allows T-cells to recognize antigenic peptides presented on the 
major histocompatibility complex (MHC) [13]. CD4+ T-cells recognize 
peptides presented on the MHC class II complex, while CD8+ T-cells 
recognize peptides presented on the MHC class I complex. Classical TCRs 
are heterodimers consisting of a paired α- and β-chain. These chains 
making up the TCR are generated through somatic recombination of V 
(variable), D (diversity) and J (joining) gene segments accompanied by 
pseudorandom insertions and deletions of nucleic acids at their joining 
regions [14], thereby giving rise to an enormously diverse TCR reper-
toire in every individual. By this process of VDJ recombination, the 
small set of genes that encode the TCR can be used to create over 1015 
potential TCR clonotypes [13,15]. Previous estimates of number of 
unique T-cells in a human range from 106 to 1011 [16–18], meaning that 
every individual only carries a small fraction of the potential repertoire. 
High throughput sequencing of TCR repertoires is emerging as a 
valuable tool to unravel the exact role of T-cells in autoimmune diseases. 
The TCR repertoire has been proposed to serve as diagnostic biomarker 
for various autoimmune diseases, and recent studies have identified 
disease-associated TCR sequences in autoimmune diseases including 
autoimmune encephalomyelitis (AE), systemic lupus erythematosus 
(SLE), and rheumatoid arthritis (RA) [19–21]. Moreover, changes in 
T-cell repertoire diversity have been suggested to predispose the path-
ological manifestations in RA patients [22]. Prior studies examining the 
TCR repertoire in SSc have shown that there is an oligoclonal expansion 
of T-cells in the skin, lungs and blood of SSc patients [23–25], suggesting 
that expanded T-cells are involved in the disease pathogenesis. How-
ever, there are limitations to the results of previous studies that have 
examined the TCR repertoire in SSc patients. These include: a) lack of 
the use of high-throughput techniques; b) consideration of either CD4+
or CD8+ or unsorted T-cell populations; and c) the study of T-cells ob-
tained only from a single time point thereby providing a static snapshot 
of the TCR repertoire in SSc. 
Two major hypotheses have been postulated to explain mechanism 
of the expansion of T-cells in the context of autoimmunity [26,27]. The 
first hypothesis states that T-cells might expand non-specifically or by 
chance (bystander activation) due to chronic inflammation observed in 
autoimmune patients [27–29]. In this case, proliferation of T-cells is 
induced through non-specific activation in the presence of TLR ligands 
and cytokines during an immune response. Due to inherent biases in the 
V(D)J recombination process, some TCRβ sequences are more prevalent 
as they have a high generation probability [30]. As a result of this bias, 
during bystander activation, naïve T-cell clones with TCRβs that have 
high generation probabilities have a larger chance of being at the site of 
action due to their increased prevalence, and therefore have a higher 
chance to expand. In this case, expansion is a result of chance. The 
second hypothesis states that clonal expansion in autoimmunity is 
driven by chronic, and specific responses to antigens that selectively 
skew the TCR repertoire [26]. Here expansion is driven by antigen 
specific selection rather than chance. It remains to be unraveled which 
of these two mechanisms contributes to the activation and expansion of 
autoreactive T-cells in SSc. 
To better understand T-cell responses in SSc pathogenesis, here we 
investigate the temporal TCR repertoire dynamics in SSc patients. We 
performed high-throughput sequencing of TCRβ chains of sorted CD4+
and CD8+ non-naive T-cells isolated from longitudinal samples from 
four SSc patients collected over a minimum of two years. 
2. Materials and methods 
2.1. Sample collection 
Whole heparinized blood samples from SSc patients were obtained 
from the University Medical Center Utrecht. SSc patients were classified 
according to the ACR/EULAR criteria [31]. This study was conducted in 
accordance with the Declaration of Helsinki and was performed with 
approval of the Institutional Review Board of the University Medical 
Centre Utrecht, The Netherlands. The medical ethics committee of the 
UMC Utrecht approved the study (METC nr. 13–697). All participants 
enrolled in the study signed informed consent, and patient samples were 
anonymized upon collection. Peripheral blood mononuclear cells 
(PBMCs) were isolated by density gradient centrifugation on 
Ficoll-PlaqueTM Plus (GE Healthcare, Uppsala, Sweden). pDCs, mDCs, 
B-cells and monocytes were first depleted by magnetic bead sorting 
using the autoMACs Pro Separator (Miltenyi Biotec, Bergisch Gladbach, 
Germany) according to the manufacturer’s protocol. The remaining 
peripheral blood lymphocytes (PBLs) were resuspended in freezing 
medium (80% FCS, (Sigma-Aldrich, Saint Louis, Missouri, USA)/20% 
DMSO, (Sigma-Aldrich)) and stored in sterile cryovials in liquid nitrogen 
(− 196 ◦C) until further use. From all patients PBLs were collected at 
baseline (T0), at least one year after inclusion (T1, ranging from 12 to 19 
months) and at least two years after inclusion (T2, ranging from 24 to 46 
months) (Fig. 1a). High-resolution HLA typing was performed on DNA 
obtained from PBMCs from one time point for each patient by next 
generation sequencing. 
2.2. T-cell sorting 
PBLs were thawed in RPMI 1640 (Gibco, Thermo Fisher Scientific, 
Waltham, Massachusetts, USA) supplemented with 20% FCS (Sigma- 
Aldrich), and washed with PBS. Subsequently, the cells were resus-
pended in FACS buffer (PBS supplemented with 1% BSA (Sigma-Aldrich) 
and 0.1% sodium azide (Sigma-Aldrich)) and stained using the following 
antibodies: CD3-AF700 (clone UCHT1, Biolegend, San Diego, California, 
USA), CD4-BV711 (clone OKT4, Sony Biotechnology, San Jose, Cali-
fornia, USA), CD8-V500 (clone RPA-T8, BD Bioscience, San Jose, Cali-
fornia, USA), CD56-PE-CF594 (clone B159, BD Bioscience), CD16- 
BV785 (clone 3G8, Sony Biotechnology), CD14-PerCP-Cy5.5 (clone 
HCD14, Biolegend), HLADR-BV421 (clone L243, Biolegend), CD45RO- 
PE-Cy7 (clone L243, BD Bioscience), CD27-APC-eFluor780 (clone 
O323, eBioscience, San Diego, California, USA). Multiparametric flow 
cytometry sorting of non-naive CD4+ T-cells (CD3+CD4+CD45RO+/ 
− CD27+/− ) and non-naive CD8+ T-cells (CD3+CD8+CD45RO+/− CD27+/ 
− ) was performed on the BD FACSAria II (BD Bioscience), according to 
the gating strategy described in Fig. 1b. After sorting, cells were washed 
in PBS, lysed in TRIzol™ Reagent (Invitrogen, Carlsbad, California, 
USA), and stored at − 20 ◦C until RNA isolation. 
2.3. RNA isolation and TCR sequencing 
RNA was isolated using the RNeasy Mini Kit (Qiagen, Venlo, 
Netherlands) by adding ethanol to the upper aqueous phase of processed 
TRIzol samples and transferring directly to the RNeasy spin columns. 
TCR amplification was performed according to the protocol published 
by Mamedov et al. [32]. Primer and barcode sequences are provided in 
Supplementary Table 1. Briefly, cDNA was generated by RACE using a 
primer directed to the TCRβ constant region. Thirteen nucleotide long 
unique molecular identifiers (UMIs) were incorporated during cDNA 
synthesis. Subsequently, two-stage semi-nested PCR amplification was 
performed including a size selection/agarose gel purification step after 
the first PCR. To minimize cross-sample contamination, 5-nucleotide 
sample specific barcodes were introduced at two steps during the li-
brary preparation process [32]. Resulting TCR amplicons were subjected 
to high-throughput sequencing using the Ovation Low Complexity 
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Fig. 1. High-throughput TCRβ sequencing of SSc patients over time shows temporal persistence of Vβ and Jβ gene segment usage. a) Experimental design of lon-
gitudinal sampling. b) Gating strategy for FACS sorting of CD4+ non-naïve and CD8+ non-naïve T-cells for PBL samples. c) Heatmap showing the frequency of Vβ and 
Jβ gene usage across different samples. d) Heatmap of Jensen-Shannon divergence of Vβ and Jβ gene usage between different samples. Lower divergence indicates 
similar Vβ/Jβ gene usage. 
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Sequencing System kit (NuGEN, San Carlos, California, USA) according 
to the manufacturer’s instructions, and the Illumina MiSeq system 
(Illumina, San Diego, California, USA), using indexed paired-end 300 
cycle runs. 
2.4. TCR repertoire analysis 
Raw paired-end reads were assembled using Paired-End reAd 
mergeR (PEAR) [33]. Sample specific barcode correction was performed 
using the ‘umi_group_ec’ command from the Recover T Cell Receptor 
(RTCR) pipeline [34], allowing zero mismatches in the barcode seed 
sequence for UMI detection (sample specific barcodes are provided in 
Supplementary Table 1). This strict barcode selection resulted in about 
50% loss of reads, but ensured that there was minimal cross-sample 
contamination. Subsequently, barcode sequence reads having the same 
UMI were collapsed into consensus sequences using the RTCR pipeline 
to accurately recover TCRβ sequences. Downstream data analysis of 
TCRβ repertoires was performed using the tcR R package [35]. 
Healthy longitudinal sequencing data [36] was obtained from the 
immuneACCESS portal of Adaptive Biotechnologies repository at: htt 
ps://clients.adaptivebiotech.com/pub/healthy-adult-time-cou 
rse-TCRB. Healthy data for validation of the diversity analysis was ob-
tained from the immuneACCESS repository for the datasets from 
Emerson et al. [37], Rowe et al. [38], Tourino et al. [39], Lindau et al. 
[40], Soto et al. [41], Savola et al. [42], and De Neuter et al. [43]. The 
processed healthy data from Wang et al. [44] was obtained from the 
supplementary data provided in their publication. 
2.5. Statistical analyses 
Statistical analyses were performed using R version 3.4.1 [45], and 
figures were produced using the R package ggplot2 [46]. Generation 
probabilities of TCRβ amino acid sequences were computed using the 
generative model of V(D)J recombination implemented by OLGA 
(Optimized Likelihood estimate of immunoGlobulin Amino-acid se-
quences) [47], using the default parameters. Diversity estimates were 
calculated by sample-size-based rarefaction and extrapolation using the 
R package iNEXT (iNterpolation/EXTrapolation) [48]. Clustering anal-
ysis was performed using the GLIPH2 [49] webtool (http://50.255.35 
.37:8080/). Significant clusters were considered based on the 
following parameters: number of samples = 3, number of CDR3 ≥ 3, 
vb_score<0.05, length_score<0.05. After filtering for significance, 
clusters were ordered based on final_score obtained from GLIPH2. 
Network graphs of clusters were produced using the R package igraph 
[50]. Unless indicated otherwise, analysis of differences was performed 
using Student t-test. For multiple group comparisons, one-way anova 
was used. P-values <0.05 were considered statistically significant. 
2.6. Availability of data 
The TCRβ sequencing data presented in this study have been 
deposited in NCBI’s Gene Expression Omnibus (GEO) database under 
GEO: GSE156980. Both raw data and processed data are available. 
3. Results 
3.1. High-throughput TCR sequencing of SSc patients 
To investigate the TCR repertoire dynamics in SSc, we performed 
high-throughput sequencing (HTS) of TCRβ chains on longitudinal 
samples obtained from four SSc patients collected over a minimum of 
two years. The clinical characteristics and HLA haplotypes of the SSc 
patients are included in Table 1. Among the SSc patients included, two 
were limited SSc (lcSSc), and two were diffuse SSc patients (dcSSc). 
From all patients PBLs were collected at baseline (T0), at least one year 
after inclusion (T1, ranging from 12 to 19 months) and at least two years 
after inclusion (T2, ranging from 24 to 46 months) (Fig. 1a). Frozen PBL 
samples were subjected to FACS sorting and sorted non-naive CD4+ T- 
cells (CD3+CD4+CD45RO+/− CD27+/− ) and non-naive CD8+ T-cells 
(CD3+CD8+CD45RO+/− CD27+/− ) were used for TCRβ sequencing 
(Fig. 1b). Sample specific barcodes and UMIs to barcode individual 
mRNA molecules were used to accurately recover TCRβ sequences using 
the RTCR pipeline [34]. We produced a total of 906 448 and 125 962 
TCRβ UMI corrected amino acid (AA) sequence reads for CD4+ and 
CD8+ T-cells respectively. The number of UMI corrected AA sequence 
reads per sample was on average 75 000 for CD4+ T-cells and on average 
10 500 for CD8+ T-cells (details see Supplementary Table 2). 
3.2. Frequency of Vβ and Jβ gene segment usage indicates temporal 
persistence of TCRβ sequences in SSc patients 
We first assessed the frequency of Vβ and Jβ gene segment usage in 
SSc patients over time (Fig. 1c). The most frequently used Vβ segments 
across all samples were V20–1, V5-1 and V7-9, for both CD4+ and CD8+
T-cells. When looking at Jβ segment usage, J2-7, J2-1 and J2-3 were 
most frequently observed. In previous studies, these Vβ (V20–1, V5-1 
and V7-9) and Jβ genes (J2-7, J2-1 and J2-3) were also identified as 
the most frequently used genes in both healthy and diseased individuals 
[51,52], reflecting known intrinsic biases in the V-D-J rearrangement 
process [53]. Additionally, Vβ2, which we identified with a relatively 
Table 1 
Clinical characteristics of patients included. Time from T0 is indicated in months after the first sample was taken. Abbreviations: dcSSc = diffuse SSc, lcSSc = limited 
SSc, M = male, F = female, ILD = interstitial lung disease (1 = yes, 0 = no), ANA = anti-nuclear antibodies (1 = yes, 0 = no), mRSS = modified rodman skin score, unk 
= unkown.  
Patient Time Months Subset Age Sex ILD ANA mRSS HLA-A HLA-B HLA-C HLA-DRB1 HLA-DQB1 HLA-DPB1 












T1 19 dcSSc   1 1 11        
T2 34 dcSSc   1 1 11       












T1 12 dcSSc   0 1 13        
T2 25 dcSSc   0 1 13       










T1 18 lcSSc   1 1 4        
T2 42 lcSSc   1 1 8       












T1 15 lcSSc   0 1 2        
T2 46 lcSSc   0 1 2        
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Fig. 2. SSc TCRβ repertoires are highly stable over time and are dominated by persistent TCRβ sequences. a) Heatmap showing high overlap (dark blue, morisita 
index) of TCR sequences within individuals and limited overlap (light blue) of TCR clones between individuals for CD4+ T-cells and b) CD8+ T-cells. c) Overlap 
between T-cell sequences within SSc patient 4 over time for CD4+ T-cells and d) CD8+ T-cells. Each dot on the scatter plots indicates a single TCR sequence. Axes 
denote frequency of sequences. Persistent sequences are shown in blue and non-persistent sequences in grey. Frequency was calculated based on the total reads for 
each sample. Density curves indicate the distribution of sequences across the samples. e) Venn diagram showing the exact number of persistent and non-persistent 
TCR sequences within each patient for CD4 and CD8 T-cells. f) Boxplots showing the fraction of total reads per sample (y-axis) across the different samples. Majority 
of reads is coming from sequences persistent across all time points (blue) or occurring in at least two time points (red). (For interpretation of the references to colour 
in this figure legend, the reader is referred to the Web version of this article.) 
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high frequency in CD4+ and CD8+ T-cells, was previously found to be 
one of the most frequent Vβ chains in peripheral blood T-cells in SSc 
patients in another study [54], showing that disease specific patterns are 
also present. Furthermore, we also observed individual specific patterns 
of Vβ and Jβ segments. As an example, SSc patient 2 displayed a lower 
frequency of V-28, V7-2 and J2-5 in both CD4+ and CD8+ T-cells across 
all time points compared to the other patients (Fig. 1c). 
In order to quantify the relative similarity of Vβ and Jβ gene segment 
usage across all samples, we calculated the Jensen-Shannon divergence 
(JSD) between them (Fig. 1d). The JSD ranges from 0 to 1. A JSD of 
0 indicates identical Vβ and Jβ segment usage, while a JSD of 1 indicates 
that the Vβ and Jβ segment usage is distinct between two samples. When 
comparing the JSD between samples taken from the same patient, we 
observed that the use of Vβ and Jβ segments for both CD4+ and CD8+ T- 
cells was rather consistent over time, while samples taken from different 
patients displayed a higher divergence amongst each other (Fig. 1d). 
Moreover, when comparing the differences in JSD between Vβ and Jβ 
segment usage, we observed that Vβ usage (Fig. 1d, right panels) was 
more variable then Jβ segment usage (Fig. 1d, left panels) across 
different individuals. This difference in variability between Vβ and Jβ 
usage is to be expected since the TCRβ locus has more Vβ than Jβ gene 
segments (according to the ImMunoGeneTics (IMGT) database [55]), 
resulting in a greater potential variability for Vβ segment usage. Overall 
this analysis shows that, Vβ and Jβ gene segment usage is largely 
persistent within SSc patients over time. 
3.3. SSc TCRβ repertoires are highly stable over time 
Apart from examining persistence in the use of Vβ and Jβ segments, 
we wanted to further examine the persistence of full CDR3 amino acid 
sequences within SSc patients over time. In order to quantify the overlap 
in TCRβ repertoire between different samples, Morisita’s overlap index 
was calculated to intersect amino acid CDR3 sequences. This index 
ranges from 0 (no overlapping sequences) to 1 (identical repertoires). 
Overlap analysis revealed that samples taken from the same patient 
shared a high number of sequences, indicating a clear temporal persis-
tence of the repertoire within patients, while overlap was extremely 
limited between samples taken from different patients. This pattern was 
consistent over all time points, for both CD4+ and CD8+ T-cells (Fig. 2a 
and Fig. 2b respectively). These results demonstrate that the TCRβ 
repertoire in SSc patients is highly unique and stable over long periods of 
time, also at the level of exact CDR3 amino acid sequences. 
Next we examined whether the frequencies of TCRβ sequences were 
also consistent over time. We observed that TCRβ sequences that were 
found with a high frequency at one time point were also found with a 
high frequency at the other time points collected from the same patient, 
for both CD4+ and CD8+ T-cells (Fig. 2c and d respectively). This shows 
that the frequencies of highly abundant TCRβs within SSc patients are 
largely consistent over long periods of time, even after almost four years 
of follow-up for SSc patient 4. Persistence of dominant TCRβ sequences 
was observed for all the SSc patients included in our study, for both 
CD4+ and CD8+ T-cells (Supplementary Figure S1). The exact number of 
TCRβ amino acid sequences overlapping between samples taken from 
the same patient are shown in Fig. 2e. Although the absolute number of 
sequences that are overlapping within patients over time (i.e. persistent 
sequences) are low, they make up a substantial part of the samples in 
terms of abundance, based on UMI corrected reads, as shown in Fig. 2f. 
These results clearly demonstrate that SSc repertoires are largely 
dominated by persistent sequences. 
In order to investigate whether persistent TCRβ sequences have any 
known antigen specificity, we queried the sequences that were persis-
tently present in all three time points for every patient in VDJdb (a 
curated database of TCR sequences with known antigen specificities) 
[56]. The results of this analysis are shown in Table 2. In this table we 
show the hits for peptides presented on MHC II for CD4+ T-cells and 
peptides presented on MHC I for CD8+ T-cells, matching with the HLA 
haplotype of the patient from which the sequences were obtained. 
For persistent TCRβs from CD8+ T-cells, we mainly found associa-
tions with peptides related to viral antigens including EBV, CMV, 
influenza and HIV (Table 2). For SSc patient 2, we identified one TCRβ 
sequence (CASSRLAGGTDTQYF) associated with both CMV and HIV-1. 
This TCRβ sequence most likely represents a hit against CMV in patient 
2, as all the patients included in our study are known to be HIV-1 
negative. For persistent TCRβs from CD4+ T-cells, we identified two 
persistent sequences (CASSLEETQYF and CASSLGGEETQYF) associated 
with CMV. No hits against TCRβ sequences associated with human 
autoantigens where identified in VDJdb. However, the vast majority of 
the records present in VDJdb are based on studies of viral and cancer 
epitopes, while TCRβ sequences associated with autoantigens remain 
understudied. 
Overall, these results reveal a clear temporal persistence of clonally 
expanded CD4+ and CD8+ T-cells in SSc patients, and we show that the 
TCRβ repertoire in SSc patients is highly stable over time. 
Table 2 
Epitope specificity of persistent TCRβs (occurring in all three time points within a patient), according to VDJdb. For CD4+ TCRβ sequences, specificities for peptides 
presented on MHC II are given and for CD8+ TCRβ sequences, specificities for peptides presented on MHC I are given. Only results for HLA molecules matching the HLA 
haplotype of the specific patients are given. Sequences indicated with an asterisk (*) are identical.  
CD4 - MHC II  
CDR3 MHC A MHC B Epitope Species 
SSc 3 CASSLEETQYF HLA-DRA*01:01 HLA-DRB1*15 pp65 CMV 
SSc 3 CASSLGGEETQYF HLA-DRA*01:01 HLA-DRB1*15 pp65 CMV 
CD8 - MHC I  
CDR3 MHC A MHC B Epitope Species 
SSc 1 CASSWGQGSNYGYTF HLA-A*11:01 B2M EBNA3B EBV  
SSc 2 CASSLGQAYEQYF HLA-B*08:01 B2M EBNA3A EBV 
SSc 2 CASSPGQGEGYEQYF HLA-B*08:01 B2M BZLF1 EBV 
SSc 2 CASSPGTGEGYEQYF HLA-B*08:01 B2M BZLF1 EBV 
SSc 2 CASSRLAGGTDTQYF* HLA-B*08:01 B2M Gag HIV-1 
SSc 2 CASSRLAGGTDTQYF* HLA-B*08:01 B2M IE1 CMV  
SSc 3 CSARDRTGNGYTF* HLA-A*02:01 B2M BMLF1 EBV 
SSc 3 CSARDRTGNGYTF* HLA-A*02:01 B2M M Influenza 
SSc 3 CSARDRTGNGYTF* HLA-A*02:01 B2M BMLF1 EBV 
SSc 3 CASSPTDTQYF HLA-A*02 B2M pp65 CMV  
SSc 4 CASSVGQAYEQYF HLA-B*08:01 B2M EBNA3A EBV  
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Fig. 3. Comparison of TCRβ characteristics between persistent and non-persistent sequences. a) Density plots showing the distribution of lengths of TCR amino acid 
sequences (x-axis), based on incidence. Distribution of lengths of persistent (blue) and non-persistent (grey) TCR sequences are shown. b) Line plots showing the 
distribution of lengths of TCR amino acid sequences (x-axis), based on abundance. c) Bar plot showing the frequency (y-axis) of TCR Vβ and Jβ gene segments (x-axis) 
of persistent sequences (blue) compared to non-persistent (grey) sequences. Every dot represents one sample. T-tests were performed to test if the gene usage was 
significantly different between persistent and non-persistent sequences (* = p < 0.05). (For interpretation of the references to colour in this figure legend, the reader 
is referred to the Web version of this article.) 
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3.4. Persistent clones display common features across SSc patients 
Previously, TCRs in the context of autoimmune disease have been 
associated with certain characteristics such as shorter length and a bias 
in Vβ/Jβ-gene segment usage [21,39,57]. To further investigate the 
potential involvement of persistent TCRβs identified in SSc patients in 
autoimmune responses, we computed the distribution of lengths of all 
the TCRβ amino acid sequences and compared the lengths of persistent 
and non-persistent TCRβs. The lengths were calculated based on both 
incidence (without weighing sequences by their abundance) and abun-
dance (also taking into account the frequency of the sequences). A 
Gaussian distribution of lengths was observed for both persistent and 
non-persistent sequences, in CD4+ as well as CD8+ T-cells, when looking 
at incidence (Fig. 3a), and distribution of lengths of sequences was 
similar between persistent and non-persistent sequences in all samples 
(two sample Kolmogorov-Smirnov tests >0.05 for all comparisons). 
When comparing the distribution of CDR3 lengths of persistent and 
non-persistent sequences based on abundance, we again observed no 
significant differences in the distributions neither for CD4+ nor CD8+
T-cells (two sample Kolmogorov-Smirnov tests >0.05 for all compari-
sons, Fig. 3b). Although the CDR3 length distributions where not 
significantly different between persistent and non-persistent sequences, 
In SSc patient 1 and 2, more shorter length sequences were observed in 
the persistent TCRβs, while in SSc patient 4, longer sequences were 
found (Fig. 3b). However, this skewness in lengths is mainly caused by 
the expansion of few dominant TCRβ sequences. 
Next to comparing lengths, we also compared the frequencies of Vβ 
and Jβ segment usage between persistent and non-persistent TCR se-
quences to see if there was any preferential usage (Fig. 3c). Although 
most differences observed were small, we identified various Vβ and Jβ 
gene segments that had either higher or lower frequencies in persistent 
sequences across all SSc patients. As an example, TRBJ1-2 had a 
significantly lower frequency in persistent sequences in CD4+ as well as 
CD8+ T-cells across all SSc patients, while the frequency of TRBV7-2 and 
TRBV7-3 was higher in persistent sequences in CD4+ and CD8+ T-cells 
respectively (Fig. 3c). This analysis demonstrates that, although the 
number of exact sequences that are shared between SSc patients is low, 
TCRβ sequences that are persistently present in SSc patients over time 
show similarities in terms of Vβ and Jβ usage. Moreover, these are 
significantly different from non-persistent sequences, showing that 
persistent sequences display preferential usage of Vβ and Jβ segments 
across SSc patients. Given that similar TCR sequences are thought to be 
involved in T-cell responses to similar antigens [58–61], the preferential 
segment Vβ and Jβ segment usage across SSc patients over time might 
reflect chronic immune responses against antigens that are commonly 
present across patients. 
3.5. SSc TCRβ repertoires are less diverse than healthy memory 
repertoires 
The persistence of highly abundant TCRs is not necessarily unique to 
autoimmune repertoires and has in fact previously been observed in 
healthy individuals [36]. Therefore, we also compared our SSc data to a 
public dataset of longitudinal TCRβ sequences from healthy donors [36]. 
To investigate whether TCRβs in SSc patient repertoires are aberrantly 
expanded compared to healthy repertoires, we compared the Shannon 
diversities of healthy memory repertoires to those of SSc. As the samples 
differed in their sizes, to compare the diversity between samples we 
performed rarefaction analysis. The healthy control dataset from Chu et 
al. included here did not contain singletons (sequences represented by 
one read). We therefore performed rarefaction analysis and estimated 
Shannon diversity in our SSc patient data by including and excluding 
singletons. In Fig. 4a, we show the estimated Shannon diversity based on 
the rarefied and extrapolated data excluding singletons. The estimated 
species richness and Shannon diversity was significantly lower in SSc 
CD4+ and CD8+ T-cell repertoires as compared to the healthy memory 
repertoire (p-value <0.05, Fig. 4b). To estimate the effect of excluding 
singletons on the diversity, the same analysis was also performed 
including the SSc singletons. In this analysis, the estimated Shannon 
diversity of TCRβ sequences obtained from SSc CD8+ T-cells were still 
significantly lower than the diversity of healthy memory cells, while the 
significant difference in diversity with the CD4+ T-cells was no longer 
observed (Supplementary Figure S2a-b). 
Additionally, next to the decreased diversity of SSc repertoires versus 
healthy repertoires, we also observed a decreased diversity of the SSc 
CD8+ repertoire versus the SSc CD4+ repertoire. Given the fact that 
there was a substantial difference in sequencing depth between CD4+
and CD8+ T-cells in our analysis (Supplementary Table 2), we wanted to 
confirm the results from the rarefaction analysis in a separate sub-
sampling analysis. We repeated the diversity analysis for 100 random 
subsamples obtained from SSc CD4+ T-cells and compared these results 
to the results obtained from SSc CD8+ T-cells. In all subsamples 
analyzed, CD8+ T-cells had a significantly lower diversity than the CD4+
T-cells (Supplementary Figure S2c), corroborating with the results from 
the rarefaction analysis from the original/complete data. 
As the healthy control dataset from Chu et al. contains some technical 
Fig. 4. SSc TCRβ repertoires have a decreased diversity compared to healthy memory repertoires. a) Sample based rarefaction and extrapolation curves. Solid lines 
depict observed data, dashed line depict extrapolated data. Calculated for all healthy memory samples (blue), SSc CD4 (yellow) and SSc CD8 samples (grey). Every 
line represents one sample. b) Boxplots show median of asymptotic diversity estimates calculated from the rarefied and extrapolated data shown in G. ***p < 0.001, 
****p < 0.0001 (one way anova). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
N.H. Servaas et al.                                                                                                                                                                                                                             
Journal of Autoimmunity 117 (2021) 102574
9
differences from our SSc dataset (e.g. DNA versus RNA, no distinction 
between CD4+/CD8+ T-cells, exclusion of singletons), we compared the 
diversity observed in SSc repertoires versus healthy donors in eight 
additional datasets. The eight additional datasets included TCRβ rep-
ertoires from sorted CD4+/CD8+ T-cells isolated from healthy in-
dividuals (see Supplementary Table 3). We compared Shannon 
diversity, estimated by rarefaction analysis, for all eight datasets with 
our SSc dataset (Supplementary Figure 3). For datasets excluding sin-
gletons, we also excluded singletons from the SSc data. We were able to 
validate the decreased diversity observed in SSc patients for both CD4+
and CD8+ T-cells for the vast majority of the datasets analyzed. In more 
detail, in six out of seven datasets containing CD4+ T-cells, Shannon 
diversity was significantly lower in SSc as compared to CD4+ T-cells 
from healthy individuals. For all five datasets containing CD8+ T-cells, 
Shannon diversity was significantly lower in SSc as compared to CD8+ T- 
cells from healthy individuals. 
Overall, these results demonstrate that the TCRβ repertoire diversity 
is lower in SSc patients compared to healthy individuals. This provides 
evidence for a skewed, clonally expanded repertoire in SSc, potentially 
due to chronic antigen driven T-cell responses. 
3.6. Persistent frequency of dominant TCR sequences is driven by 
antigenic selection rather than bystander activation 
The hypothesis of 1) bystander activation due to chronic inflamma-
tion and 2) clonal expansion driven by the chronic presence of antigens 
Fig. 5. Frequencies of dominant TCRβ sequences are not driven by generation probabilities in SSc patients. a) Linear regression plot between frequency (x-axis) and 
generation probability (y-axis) of one representative plot of taken from SSc CD4+ T-cells (patient 4, time point 0). Red line indicates the linear regression model fit. b) 
Linear regression plot between frequency and generation probability of one representative plot of taken from SSc CD8+ T-cells (patient 4, time point 0). c) Linear 
regression plot between frequency and generation probability of one representative plot of taken from healthy naïve T-cells (donor 1, time point 4). d) Linear 
regression plot between frequency and generation probability of one representative plot of taken from healthy memory T-cells (donor 1, time point 4). e) Histograms 
showing the distribution of p-values (left) and slopes (right) for linear regression between frequency and generation probability (computed using OLGA) of sub-
samples of healthy donor naïve T-cell samples (donor 1, time point 4). Distribution over 100 different subsamples is shown. Red bars in the p-value histogram 
indicates p-value ≤ 0.05. Red dashed line in the slope histogram indicates the mean slope for the 100 subsamples. f) Distribution of p-values (left) and slopes (right) 
for linear regression between frequency and generation probability of subsamples of healthy donor memory T-cell samples (donor 1, time point 4). (For interpretation 
of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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skewing the TCR repertoire have been proposed. To test the hypothesis 
of bystander activation, we investigated whether easy to generate TCRβ 
sequences (having high generation probabilities) are present at high 
frequencies in SSc patients. To this extend, we calculated the generation 
probabilities (pgens) of the TCRβs identified in SSc patients using OLGA 
[47]. We then used linear regression to model the relationship between 
TCRβ frequency and pgen. Using this analysis, we show that in SSc CD4+
and CD8+ T-cells, TCRβ frequency and pgen are not related (p-value 
>0.05, Fig. 5a and Fig. 5b for CD4+ and CD8+ T-cells respectively). This 
indicates that T-cells persistent in SSc patients have not expanded 
because of random bystander effects. 
For naive T-cells isolated from healthy individuals, we found a sig-
nificant positive correlation between the pgen and abundance of TCRβs 
(p-value <0.05, Fig. 5c). For memory T-cells isolated from the same 
healthy individuals, we also observed a significant positive correlation 
between pgen and abundance of TCRβs (p-value <0.05, Fig. 5d). 
Notably, the slope for memory T-cells was lower than that observed for 
the naïve T-cells (0.00018 versus 0.0165, respectively). From this 
analysis we show that for naïve and memory TCRβs obtained from 
healthy individuals, pgen and abundance are positively correlated, 
whereas in non-naive SSc T-cells no relationship between pgen and 
abundance is observed. However, as the samples obtained from healthy 
individuals were sequenced more deeply than our SSc samples, this 
observed difference in correlation might be confounded by sequencing 
depth. Therefore, we repeated the linear regression analysis for 100 
random subsamples obtained from the healthy dataset and compared 
these results to the results obtained from SSc samples. Upon sub-
sampling of the naïve healthy T-cells, 89% of the slopes observed the in 
linear regression were significantly different from zero (linear regression 
p-value <0.05 and slope >0, as indicated by the red bars in Fig. 5e), 
confirming that indeed there is a positive relationship between pgen and 
abundance for TCRβs obtained from healthy naïve T-cells. However, 
when looking at healthy memory T-cells, we did not confirm the cor-
relation between frequency and pgen that was observed in the full 
sample (p-value <0.05 in 7% of subsamples, Fig. 5f), showing that in 
healthy memory T-cells there is no clear correlation between TCRβ pgen 
and abundance. Thus, subsampling analysis shows that in both healthy 
memory T-cells and SSc non-naïve CD4+ and CD8+ T-cells, TCRβ pgen 
and abundance are not correlated. These results suggest that the more 
abundant TCRβs in SSc repertoires are likely there because of selection, 
similar to what is observed in healthy memory repertoires, rather than 
bystander activation of naïve T-cells that are not antigen specific. 
3.7. Clusters of similar TCRβ sequences can be identified in SSc patients 
over time 
In order to identify TCRβs in SSc patients that are potentially 
involved in chronic autoimmune responses, we used “Grouping of 
Lymphocyte Interactions by Paratope Hotspots” (GLIPH2), that employs 
sequence similarity and motif analysis to group TCR sequences that 
potentially recognize the same epitope [49]. To screen for antigen spe-
cific TCRβ clusters, we used all sequences obtained from every time 
point for each individual SSc patient as an input for GLIPH2. In order to 
exclude false positives, for each patient we considered the clusters that 
contained sequences from all time points, had at least three unique 
CDR3s, had similar CDR3 lengths (length score <0.05), and shared 
similar Vβ-gene frequency distributions (Vβ score <0.05). The number 
of clusters that were obtained for every patient for CD4+ and CD8+
T-cells are given in Table 3. 
Significant clusters were identified in all patients, either based on 
global similarity (CDR3 sequence differing by maximum one amino 
acid) or local similarity (shared motif within CDR3 amino acid region). 
All clusters identified by GLIPH2 are given in Supplementary Table 4. In 
Fig. 6a, an example network of TCRβ sequences based on clustering 
analysis by GLIPH2 in CD4+ T-cells is given. Red and purple nodes 
within this network represent TCRβs that are persistently present in 
three or two time points respectively, while blue shaded nodes represent 
sequences are found only in one time point. Nodes are connected when 
they are part of the same cluster as identified by GLIPH2. Global and 
local motifs are indicated in green and orange respectively. A “%” sign 
within the motif indicates a variable amino acid across the sequences in 
which that particular motif is present. 
Within the network, persistent TCRβs share motifs with other 
persistent and non-persistent TCRβs sequences. This shows that persis-
tent TCRβ sequences cluster together with other, similar TCRβ se-
quences, potentially representing groups of T-cells responding to the 
same antigen. The top 10 clusters, based on final cluster score outputted 
by GLIPH2, and their corresponding motifs for this network are given in 
Fig. 6b. Some clusters also shared TCRβ sequences with other clusters 
within a patient, showing that clusters also display convergence be-
tween each other (Fig. 6c, top 3 clusters are shown). Similar results were 
obtained for CD8+ T-cells, where we also identified many clusters of 
persistent and non-persistent TCRβs sharing motifs within the CDR3 
region (Fig. 6d–f). These results demonstrate that, apart from the pres-
ence of individual persistent clonally expanded T-cells, clusters of T-cells 
with potentially similar specificities are present within SSc patients over 
time. 
Lastly, we performed an overlap analysis of all motifs from signifi-
cant clusters identified by GLIPH2 between the different SSc patients 
(Fig. 6g and h). We did not observe any motifs for CD4+ T-cells or for 
CD8+ T-cells that overlap between all four patients. For the CD4+ T- 
cells, there were 11 motifs that were identified in clusters from three out 
of four SSc patients (Fig. 6g). These represent groups of T-cells that are 
likely to recognize the same or highly similar antigens across SSc pa-
tients, which could potentially be involved in SSc pathogenesis. We also 
performed the GLIPH2 analysis on the data from memory T-cells for 
healthy donors obtained from Chu et al. [36]. For this analysis, the same 
parameters as for SSc were used, however, as for healthy donor 1 and 
healthy donor 2, memory T-cells were obtained from only two time 
points, for these donors we also considered clusters that had at least two 
unique CDR3s to be significant. The number of significant clusters that 
were obtained for the memory T-cells obtained from healthy donors is 
given in Supplementary Figure 4a. In order to determine whether the 11 
motifs that we found overlapping in CD4+ TCRβ clusters between SSc 
patients were specific for SSc, we overlapped them with the motifs ob-
tained from the healthy donor memory T-cells. Of the 11 motifs, 2 (S% 
TTDT and S%DRAYE) were found to be uniquely present in SSc patients 
(Supplementary Figure 4b). In order to investigate whether these motifs 
have been associated to known antigens, we queried them against the 
VDJdb motif database, which contains several curated CDR3 motifs 
specific to different epitopes [56]. No hits were identified for these 
motifs. 
Table 3 
Number of clusters identified by GLIPH2 within SSc patients. All sequences from 
all time points from each patient (for the two cell types) were used as input for 
GLIPH2. The total clusters column represents the total number of clusters 
identified by GLIPH2. The significant clusters column represents the number of 
significant clusters (consisting of sequences from all three time points, at least 
three unique CDR3s, length score <0.05, and Vβ score <0.05).  
Cell type Patient Total clusters Significant clusters 
CD4 SSc 1 7800 204 
SSc 2 50365 3735 
SSc 3 34882 554 
SSc 4 22674 550 
CD8 SSc 1 335 2 
SSc 2 534 23 
SSc 3 453 22 
SSc 4 1500 106  
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Fig. 6. Clustering analysis of similar TCRβ sequences in SSc patients over time. a) Network of TCRβ clusters identified by GLIPH2 in CD4+ T-cells from SSc patient 4. 
Every node represents one TCRβ sequence. Red nodes represent TCRβs persistent across three time points within a patient, purple nodes represent TCRβs persistent 
across two time points within a patient, and blue shaded nodes represent TCRβs present at a single time point. Nodes are connected if they share a motif or a have 
similar CDR3 region sequence. b) Top ten clusters identified by GLIPH2 in CD4+ T-cells from SSc patient 4. For each cluster, the motif identified by GLIPH2 is given. 
Motifs with global similarity (CDR3 sequence differing by maximum one amino acid) are indicated in green, while motifs with local similarity (shared motif within 
CDR3 amino acid region) are indicated in orange. c) Top three clusters in CD4+ T-cells of SSc 4. For each cluster a sequence logo is given based on the TCRβ se-
quences present in the cluster. d) Network of TCRβ clusters identified by GLIPH2 in CD8+ T-cells from SSc patient 4. e) Top ten clusters identified by GLIPH2 in CD8+
T-cells from SSc patient 4. f) Top three clusters in CD8+ T-cells of SSc 4. (For interpretation of the references to colour in this figure legend, the reader is referred to 
the Web version of this article.) 
N.H. Servaas et al.                                                                                                                                                                                                                             
Journal of Autoimmunity 117 (2021) 102574
12
4. Discussion 
Identification of TCR sequences that are associated with the chronic 
autoimmune response in SSc will help to get more insights into the 
autoimmune pathogenesis of the disease, and will help to identify the 
antigenic triggers that underlie these responses. Our analysis reveals 
that the peripheral blood TCRβ repertoire of SSc patients is highly stable 
over time. Moreover, the TCRβ sequences that were found within a pa-
tient with a high frequency at one time point were also found with a high 
frequency at the other time points (even after four years), showing that 
frequencies of dominant TCRβs are largely consistent over time. These 
persistent, clonally expanded CD4+ and CD8+ T-cells are potentially 
involved in the autoimmune responses underlying SSc pathogenesis. 
Furthermore, we have shown that the persistent expansion of these T- 
cells is likely a result of antigenic selection rather than recombination 
bias, as TCRβ frequencies were not related to their respective generation 
probabilities. 
When we queried the persistent TCRβs found in our SSc patients in 
VDJdb, we obtained several hits for TCRβ sequences that are known to 
be associated with viral antigens from influenza, CMV and EBV, espe-
cially in the CD8+ T-cell compartment. SSc patient 4 has a CMV and EBV 
positive status, and TCRβ sequences associated with CMV and EBV were 
identified in this patient. For the other SSc patients included in this 
study, the CMV and EBV status are unknown. Interstingly, EBV and CMV 
infections have been shown to be environmental risk factors for SSc 
[62–65], and molecular mimicry between chronic viral antigens and 
human autoantigens has been proposed as a potential driver for auto-
immune disease [66]. 
Chu et al. have previously shown that subsets of persistent TCRβs are 
also present within healthy individuals [36]. Thus, persistence of TCR 
sequences in itself is likely not just a characteristic of autoimmune 
related repertoires. However, the temporal dynamics of the TCR reper-
toire in healthy individuals in the aforementioned study have only been 
investigated over a period of one year, so it remains to be seen whether 
this stability is also maintained in healthy individuals over longer pe-
riods of time, as is observed in SSc in our study. Moreover, whereas the 
previous study looked into the total pool of memory T-cells, we show 
that persistent TCRβs can be identified in both the CD4+ and CD8+
memory T-cell compartments separately. 
When further comparing the TCR repertoires of CD4+ and CD8+ T- 
cells from SSc patients to repertoires obtained from healthy memory T- 
cells, we found that SSc repertoires have lower diversity. Indeed, 
decreased diversities of TCRβ repertoires as compared to healthy have 
been observed in other autoimmune diseases [20,52,67], and have been 
proposed as a characteristic of autoimmune repertoires. Interestingly, in 
SSc, differences in the diversity of the TCR repertoire have also been 
observed between responders and non-responders after autologous he-
matopoietic stem-cell transplantation (AHSCT, the only therapy with 
long-term clinical benefit in SSc), with non-responders having a less 
diverse repertoire [68]. This provides further evidence that decreased 
TCR repertoire diversity contributes to the autoimmune pathogenesis of 
SSc. 
Determinant spreading has been proposed as a pathogenic event in 
various autoimmune diseases. During determinant spreading, an anti-
genic epitope can induce an immune response against other, distinct 
epitopes on the same protein or other proteins in the same tissue. Those 
epitopes then become additional targets for the immune response. In 
systemic sclerosis, vascular damage or skin injury could induce an 
autoimmune response against epitopes that are normally sequestered 
[69]. It has been proposed that during determinant spreading, diversi-
fication of the TCR repertoire occurs as various TCRs would be expected 
to respond against the novel epitopes. However, this response is thought 
to be dynamic and although diversification of the repertoire may occur 
in early stages of the disease, at later time points the response might 
become more restricted [70]. Following this line of thought, as the SSc 
patients in our study have more established forms of the disease (lcSSc 
and dcSSc), we expect to see a more skewed TCR repertoire. Indeed 
when comparing the diversity of the TCR repertoire of our SSc patients 
to healthy donors, we observe a decrease in the repertoire diversity in 
SSc. In the context of determinant spreading, it would be interesting to 
repeat this analysis in patients at earlier stages of the disease (for 
example eaSSc patients) and see if the repertoire is more diverse, which 
could imply that determinant spreading is ongoing and contributing to 
disease pathogenesis. 
In our generation probability analysis, we show that in both healthy 
memory T-cells and SSc non-naïve CD4+ and CD8+ T-cells, TCRβ pgen 
and abundance are not correlated. Therefore it is likely that in SSc pa-
tients, similar as to healthy donors, T-cell expansion is caused by antigen 
specific selection rather than bystander effects. Bystander activation of 
T-cells has been demonstrated to be driven by excessive production of 
cytokines including type I IFN, IL-15 and IL-18 for CD8+ T-cells [71], 
and IL-2 for CD4+ T-cells [72] during immunopathology. Interestingly, 
type I IFNs are implicated in SSc pathogenesis [73], and IL-15 and IL-18 
have been found to be increased in circulation of SSc patients as 
compared to healthy individuals [74,75]. This shows that SSc patients 
display a skewed pro-inflammatory milieu that favors bystander acti-
vation of T-cells. Therefore, one might expect an increased number of 
bystander expanded T-cells within these patients as compared to healthy 
individuals. However, since we observe no difference between SSc and 
healthy memory T-cells within our generation probability analysis, we 
show that bystander activation does not significantly contribute to the 
skewed clonal expansion of T-cells that we observed in SSc patients. 
Predicting T-cell reactivity towards antigens is one of the major areas 
currently investigated in the field of TCR research. Since prediction of 
TCR binding to a specific antigen is extremely challenging, current ef-
forts are more focused on identifying groups of TCRs that contain certain 
motifs within their CDR3 region [58–61]. These groups of TCRs 
comprise clones that potentially respond to the same antigen. Apart 
from exact sharing of TCRβ sequences between samples, we also iden-
tified clusters of TCRβs that share sequence motifs and were persistent 
within patients. This indicates that antigen selection reshapes the TCRβ 
repertoire in SSc. Potential antigens could include self-antigens, or 
chronic infections with pathogens (e.g., CMV or EBV, for which we 
identified associated persistent TCRβs). Interestingly, we also found 
clusters of TCRβs from CD4+ T-cells within patients that shared motifs 
with other TCRβ clusters between patients, even though these patients 
did not all share common HLA alleles. Notably, two of these motifs could 
not be detected in TCRβ clusters identified from memory T-cells of 
healthy donors. These could represent clusters of similar TCRβs that 
might contribute to more public autoimmune responses underlying SSc 
pathogenesis. The antigens that these clusters of TCRβs are potentially 
responding to remain to be identified. Although some epitope associated 
TCR CDR3 motifs have recently been identified in VDJdb [56], current 
information on antigen specific motifs is extremely sparse, especially for 
MHC II associated epitopes. Sequencing of larger (longitudinal) cohorts 
and MHC Class II tetramer studies including autoantigens are needed to 
further identify which TCR motifs can be associated with autoimmune 
disease, and link them to their potential pathogenic targets. For CD8+
T-cells, we did not find any clusters overlapping between more than two 
patients. However, in general we obtained less clusters in CD8+ T-cells 
than we did in CD4+ T-cells. This could be due to the fact that we 
sequenced less CD8+ than CD4+ T-cells, and thus this difference might 
be explained by a difference in sequencing depth between the two cell 
types. 
To validate our findings and further study the potential pathogenic 
role of antigen specific TCRβ clusters in SSc, larger patient cohorts 
should be studied. In this cohort we included a limited number of pa-
tients with similar clinical characteristics which makes it difficult to 
account for factors such as age, sex and ethnicity influencing the im-
mune system. Thus, studying larger longitudinal cohorts are needed to 
further define disease specific clusters of autoimmune associated TCRβs. 
Lastly, it would also be interesting to perform immune sequencing of SSc 
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skin to see if these TCRβ clusters/motifs can be traced back in the skin 
(the major organ affected by the disease) of SSc patients. 
5. Conclusion 
Our data provide evidence for an antigen driven expansion of CD4+/ 
CD8+ T-cells in SSc. We have identified clusters of T-cell clones that are 
highly persistent over time, and we have shown that this persistence 
likely is a result of antigenic selection. 
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